Trials / Completed
CompletedNCT00000232
Alternate Day Buprenorphine Administration, Phase IX - 14
Alternate Day Buprenorphine Administration, Phase IX
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- University of Vermont · Academic / Other
- Sex
- All
- Age
- 22 Years – 51 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if four times a subjects' daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine |
Timeline
- Start date
- 1992-03-01
- First posted
- 1999-09-21
- Last updated
- 2016-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000232. Inclusion in this directory is not an endorsement.